Biotechnology news

• Charles River Labs Licenses CRISPR/Cas9 IP from ERS Genomics

  07-12-2017 16:00
  Charles River Laboratories has expanded its available CRISPR/Cas9 offerings to include both technologies at the center of the bitter legal battle over who first invented the genome-editing application.Charles River has licensed from ERS Genomics nonexclusive access to ERS’s CRISPR/Cas9 patents, which are based on the technology that, in turn, ERS has licensed from holders of a European patent granted in March —namely the Regents of the University of California (UC), the University of
  
  Read more

• Cancer Drug Provides Neuroprotection for Huntington’s Disease

  07-12-2017 15:54
  A drug already used to treat certain forms of cancer may also be an effective therapy for Huntington's disease (HD), according to a new study led by investigators at the University of California, San Diego (UCSD). The same study also increases our understanding of how this drug (bexarotene), and other medications like it, may offer hope for other neurodegenerative diseases like Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and Parkinson's disease.Findings from the new study were publ
  
  Read more

• DNA Origami Creates the World's Smallest Mona Lisa

  07-12-2017 15:35
  Scientists at the California Institute of Technology (Caltech) have created what is possibly the world’s smallest Mona Lisa, using a mosaic of individual tiles of folded strands of DNA that, when viewed under atomic force microscopy (AFM), appears unmistakably as the enigmatic face of Leonardo da Vinci’s famous painting. The technique, developed by researchers in the laboratory of assistant professor of bioengineering Lulu Qian, Ph.D., builds on the original DNA origami technology de
  
  Read more

• Quanterix Set to Launch IPO, with Expansion and SR-X Rollout in Mind

  07-12-2017 15:32
  Quanterix today plans to launch an initial public offering (IPO) of at least $64 million, with the proceeds set to be used in part toward expanding commercial operations and supporting the planned rollout next year of its new Quanterix SR-X Ultra-Sensitive Biomarker Detection System™.Gross proceeds of the IPO could rise to $73.75 million if underwriters of the offering exercise in full their 30-day option to purchase up to 641,280 additional shares of common stock at the IPO price, less th
  
  Read more

• Advertisement

• Expansion of CSL Biotech Facility Drives Advanced Manufacturing Growth and Creates Victorian Jobs

  07-12-2017 06:00
  thumbnail Leading global biotherapeutics company CSL Limited (ASX:CSL), today officially opened a new AUD$230 million advanced manufacturing facility at its CSL
  Behring site in Broadmeadows with the assistance of Victorian Minister for Industry and
  Employment, Ben Carroll, MP. 
  
  Read more

Follow @Biotech_News_AU on Twitter!